| Patent Number |
Title Of Patent |
Date Issued |
| 7214662 |
Injectable solution of an LHRH antagonist |
May 8, 2007 |
| An aqueous injectable soution of an LHRH antagonist, such as Cetrorelix, in an organic, pharmaceutically acceptable acid, such as gluconic acid. |
| 7211588 |
N-substituted indolyl-3-glyoxylamides, their use as medicaments and process for their preparatio |
May 1, 2007 |
| The invention relates to novel N-substituted indolyl-3-glyoxylamides of the general formula I, their preparation and use as medicaments, in particular for the treatment of tumors ##STR00001## |
| 7205299 |
Indole derivatives having an apoptosis-inducing effect |
April 17, 2007 |
| The invention relates to indole derivatives which are used as drugs for treating tumor diseases, in particular when there is drug resistance against other active compounds and where there is a metastasizing carcinoma. |
| 7148195 |
LHRH antagonists having improved solubility properties |
December 12, 2006 |
| The invention relates to peptides which contain N-methylated amino acid units and have improved water solubility. Medicaments in which the peptides according to the invention are contained can be used for the treatment of hormone-dependent tumors and hormone-influenced non-malignant |
| 7087214 |
Water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the tre |
August 8, 2006 |
| The invention relates to novel, water-soluble porphyrin platinum compounds of the tetraarylporphyrin platinum derivatives type or of the hematoporphyrin platinum derivatives type with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases. In pa |
| 7056912 |
Heteroaryl derivatives and their use as medicaments |
June 6, 2006 |
| The invention relates to novel quinoline derivatives of the formula 1, to their preparation and to their use as medicaments, in particular for treating tumors. ##STR00001## |
| 7026310 |
Heteroaryl derivatives and their use as medicaments |
April 11, 2006 |
| The invention relates to novel quinoline derivatives of the formula 1, to their preparation and to their use as medicaments, in particular for treating tumors. ##STR00001## |
| 7005418 |
Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chron |
February 28, 2006 |
| The present inventions provides a method for therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction by short term induction treatment with an LH-RH antagonist for 4 to 12 weeks. According to another aspect of the |
| 6936615 |
Heteroaryl derivatives and their use as medicaments |
August 30, 2005 |
| The invention relates to novel quinoline derivatives of the formula 1, to their preparation and to their use as medicaments, in particular for treating tumors. ##STR1## |
| 6903080 |
Disease treatment with novel phospholipid derivatives |
June 7, 2005 |
| A method of treating protozoal and fungal diseases is described, in which an effective amount of a compound of formula I is administered to a host having a protozoal or fungal disease. Also described are methods of treating bone marrow damage composed of administering, to a host having |
| 6867191 |
Preparation and use of oligopeptide lyophilisate for gonad protection |
March 15, 2005 |
| A lyophilizate, method of preparation, and use of the lyophilizate for gonad protection is described. The lyophilizate comprises cetrorelix dissolved in 30% (v/v) acetic acid, transferred to water, and freeze-dried. |
| 6855723 |
Methods of modulating serine/threonine protein kinase function with azabenzimidazole-based compo |
February 15, 2005 |
| The present invention is directed in part towards methods of modulating the function of serine/threonine protein kinases with azabenzimidazole-based compounds. The methods incorporate cells that express a serine/threonine protein kinase, such as RAF. In addition, the invention describes |
| 6828415 |
Oligopeptide lyophilisate, their preparation and use |
December 7, 2004 |
| A novel lyophilizate and method of preparation as well as the use of the lyophilizate to treat female infertility and for gonad protection. Cetrorelix is dissolved in acetic acid 30% v/v, the solution is transferred to water and freeze dried. |
| 6780972 |
Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, contai |
August 24, 2004 |
| A method for producing peptide salts, including reacting an acid addition salt of a basic starting peptide in the presence of a diluent in a mixed bed ion exchanger, with a mixture of an acid and a basic ion exchanger during the formation of a free basic peptide, and then separating the |
